Literature DB >> 14631134

Risk stratification of in-hospital mortality in patients hospitalized for chronic congestive heart failure secondary to non-ischemic cardiomyopathy.

Mien-Cheng Chen1, Hsueh-Wen Chang, Cheng-I Cheng, Yen-Hsun Chen, Han-Tan Chai.   

Abstract

The study population consisted of 234 consecutive patients hospitalized for acute exacerbation of congestive heart failure secondary to non-ischemic cardiomyopathy. Of the 234 patients, there were 55 in-hospital deaths. Their medical records were deliberatively reviewed and the association of 38 clinical, hemodynamic and biochemical variables with in-hospital mortality was evaluated by multiple stepwise logistic regression analysis. The following variables were statistically associated with in-hospital mortality: profound cardiogenic shock, severe hyponatremia, the presence of ventricular arrhythmias, history of stroke, the presence of acute renal failure, and requirement of dobutamine therapy. In stratified analyses, the rates of in-hospital mortality rose rapidly as the number of risk factors increased: 0 risk factors, 2.5%; 1 risk factor, 5.1%; 2 risk factors, 36.4%; 3 risk factors, 75%, and no less than 4 risk factors, 100%. In conclusion, our study identified 6 variables that correlated with in-hospital death in patients with heart failure secondary to non-ischemic cardiomyopathy. The identification of these variables may allow more accurate risk stratification of individuals at risk of in-hospital mortality in this clinical setting. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 14631134     DOI: 10.1159/000073931

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  10 in total

Review 1.  Impact of social factors on risk of readmission or mortality in pneumonia and heart failure: systematic review.

Authors:  Linda Calvillo-King; Danielle Arnold; Kathryn J Eubank; Matthew Lo; Pete Yunyongying; Heather Stieglitz; Ethan A Halm
Journal:  J Gen Intern Med       Date:  2012-10-06       Impact factor: 5.128

2.  Worse Prognosis in Heart Failure Patients with 30-Day Readmission.

Authors:  Ying-Chang Tung; Shing-Hsien Chou; Kuan-Liang Liu; I-Chang Hsieh; Lung-Sheng Wu; Chia-Pin Lin; Ming-Shien Wen; Pao-Hsien Chu
Journal:  Acta Cardiol Sin       Date:  2016-11       Impact factor: 2.672

3.  Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry.

Authors:  Ahmad Kaddourah; Stuart L Goldstein; Steven E Lipshultz; James D Wilkinson; Lynn A Sleeper; Minmin Lu; Steven D Colan; Jeffrey A Towbin; Scott I Aydin; Joseph Rossano; Melanie D Everitt; Jeffrey G Gossett; Paolo Rusconi; Paul F Kantor; Rakesh K Singh; John L Jefferies
Journal:  Pediatr Nephrol       Date:  2015-07-26       Impact factor: 3.714

Review 4.  Hyponatremia in patients with heart failure.

Authors:  Theodosios D Filippatos; Moses S Elisaf
Journal:  World J Cardiol       Date:  2013-09-26

Review 5.  Treating hyponatremia in heart failure.

Authors:  Steven R Goldsmith
Journal:  Curr Cardiol Rep       Date:  2006-05       Impact factor: 2.931

Review 6.  Treatment options for hyponatremia in heart failure.

Authors:  Steven R Goldsmith
Journal:  Heart Fail Rev       Date:  2008-09-06       Impact factor: 4.214

Review 7.  Hyponatremia in heart failure.

Authors:  Dimitrios Farmakis; Gerasimos Filippatos; John Parissis; Dimitrios Th Kremastinos; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2008-08-29       Impact factor: 4.214

Review 8.  Diagnosis and management of hyponatremia in acute illness.

Authors:  Robert W Schrier; Shweta Bansal
Journal:  Curr Opin Crit Care       Date:  2008-12       Impact factor: 3.687

Review 9.  Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications.

Authors:  Caterina Urso; Salvatore Brucculeri; Gregorio Caimi
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

10.  Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis.

Authors:  Giovanni Corona; Corinna Giuliani; Gabriele Parenti; Dario Norello; Joseph G Verbalis; Gianni Forti; Mario Maggi; Alessandro Peri
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.